ENTITY
Pharmaessentia Corp

Pharmaessentia Corp (6446 TT)

83
Analysis
Health CareTaiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
16 Sep 2024 07:05

TWSE Foreign Holding Weekly (Sep 13th): Quanta Computer, TSMC, Ctbc Financial

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in Quanta Computer, TSMC, Ctbc Financial, Hon Hai...

Logo
477 Views
Share

Taiwan Tech Weekly: TSMC Becoming More Dominant; Apple's AI Opportunity; Taiwan Market Hammered

​TSMC extending its lead in global foundry with Intel and Samsung needing help. Apple best positioned deliver the AI phone 'dream'. Taiwan market...

Logo
669 Views
Share
09 Sep 2024 16:56

The Stocks to Own in Asia – Vol. 46

We highlight 14 stocks in Asia that look interesting to us based on our FVMR methodology. Portfolio changes: Two stock remains, 12 stocks added.

Share
09 Sep 2024 05:50

Taiwan Top 50 ETF Rebalance: Rallying PharmaEssentia To Replace Sliding Nanya Tech

Pharmaessentia will replace Nanya Tech in the Top 50 ETF at the close of trading on 20 Sep. Passives need to trade around 1x ADV in both stocks....

Logo
482 Views
Share
26 Aug 2024 17:33

Quiddity Leaderboard T50/​​​100 Sep 24: Nuvoton Tech TDIV DEL Likely; Shin Kong M&A Consequences

We expect Nuvoton Technology (4919 TT) to be deleted from the T100 index in September 2024. Since this name is a TDIV member, it is likely to be...

Share
x